Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10
At 2.4 mg, the target dose for phase 3 trials, the benefit-to-risk ratio appeared optimal
1c, compared to other ECSCs, ECSC isk displayed the most spheres
Add-Ons We offer professional waxing services with high-quality products
For those with significant deficiencies, this may be less efficient than the higher, less frequent doses provided by injections
US$ 26.15
US$ 20.83
US$ 29.07
US$ 29.65
